Table 1.
Correlation between GLO1high/nuc staining and patient characteristics
| GLO1high/nuc | GLO1others | |||||
|---|---|---|---|---|---|---|
| Features | Category | N | % | N | % | p value3 |
| Age [years] | < 58.25 | 18 | 64.3 | 63 | 49.2 | 0.148 |
| ≥ 58.25 | 10 | 35.7 | 65 | 50.8 | ||
| Gender | Male | 20 | 71.4 | 96 | 75.0 | 0.695 |
| Female | 8 | 28.6 | 32 | 25.0 | ||
| T status | T1-T2 | 6 | 21.4 | 64 | 50.4 | 0.005 |
| T3-T4 | 22 | 78.6 | 63 | 49.6 | ||
| N status | N0 | 6 | 21.4 | 25 | 19.7 | 0.835 |
| N+ | 22 | 78.6 | 102 | 80.3 | ||
| M status | M0 | 25 | 92.6 | 120 | 96.0 | 0.444 |
| M+ | 2 | 7.4 | 5 | 4.0 | ||
| Pathological grading | G1–2 | 14 | 66.7 | 62 | 56.4 | 0.381 |
| G3 | 7 | 33.3 | 48 | 43.6 | ||
| Clinical staging | I-III | 5 | 17.9 | 44 | 34.6 | 0.084 |
| IV | 23 | 82.1 | 83 | 65.4 | ||
| Alcohol | no/former | 3 | 11.1 | 29 | 24.2 | 0.137 |
| current | 24 | 88.9 | 91 | 75.8 | ||
| Tobacco | no/former | 3 | 11.1 | 29 | 23.8 | 0.147 |
| current | 24 | 88.9 | 93 | 76.2 | ||
| HPV | non-related1 | 24 | 88.9 | 83 | 75.5 | 0.130 |
| related2 | 3 | 11.1 | 27 | 24.5 | ||
1 viral DNA-negative or DNA-positive but transcript-negative; 2 viral DNA- and transcript-positive according to [20]; 3 Chi-square test
Significant results (p <0.05) (including the HR, 95% CI) are marked in boldface